Bioventus Inc.·4

Apr 12, 8:26 PM ET

Bihl Anthony P III 4

4 · Bioventus Inc. · Filed Apr 12, 2023

Insider Transaction Report

Form 4
Period: 2023-04-10
Bihl Anthony P III
DirectorInterim CEO
Transactions
  • Award

    Restricted Stock Units

    2023-04-10+76,00076,000 total
    Class A Common Stock (76,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2023-04-10+198,000198,000 total
    Exercise: $1.16Exp: 2033-04-10Class A Common Stock (198,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
  • [F2]The RSUs and options, as applicable, vest on April 10, 2024.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT